EcoDrugPlus

Epidermal Growth Factor Receptor-Like

Ensembl ID : ENSDCDG00000035745
Gene Symbol: LOC114769440
2 Cross references
213 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSDCDG00000013741
Gene Symbol: ERBB3
3 Cross references
211 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSDCDG00000029753
Gene Symbol: ERBB4
1 Cross references
241 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSDCDG00000027895
Gene Symbol: ERBB4
3 Cross references
225 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSDCDG00000033662
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSDCDG00000001511
Gene Symbol: ESR2
3 Cross references
208 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSDCDG00000032666
Gene Symbol: LOC114803015
3 Cross references
200 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSDCDG00000011182
Gene Symbol: ESRRG
3 Cross references
201 Possible Orthologues:

Exportin 1

Ensembl ID : ENSDCDG00000015851
Gene Symbol: XPO1
3 Cross references
301 Possible Orthologues:

Exportin 1

Ensembl ID : ENSDCDG00000027989
Gene Symbol: XPO1
3 Cross references
301 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSDCDG00000005308
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSDCDG00000033739
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).